Home/Filings/4/0001493152-24-032463
4//SEC Filing

Morris Jeffrey Allen 4

Accession 0001493152-24-032463

CIK 0000315545other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 7:19 PM ET

Size

6.8 KB

Accession

0001493152-24-032463

Insider Transaction Report

Form 4
Period: 2024-08-12
Transactions
  • Conversion

    Series D-1 Convertible Preferred Stock

    2024-08-12$2.86/sh+264,314$756,4674,260,061 total
Holdings
  • Common Stock

    12,000,000
  • Common Stock

    (indirect: By IRA)
    6,500,000
Footnotes (3)
  • [F1]The reporting person has sole voting and dispositive power over 12,000,000 shares of Common Stock.
  • [F2]The reporting person has sole voting and dispositive power over 6,500,000 shares of Common Stock owned through an IRA retirement plan.
  • [F3]The reporting person has sole voting and dispositive power over 4,260,061 shares of Series D-1 Convertible Preferred Stock, convertible into 42,600,610 shares of Common Stock.

Documents

1 file

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.

CIK 0000315545

Entity typeother

Related Parties

1
  • filerCIK 0001959175

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 7:19 PM ET
Size
6.8 KB